Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 8

1.

UGT1A1 promoter polymorphism increases risk of nilotinib-induced hyperbilirubinemia.

Singer JB, Shou Y, Giles F, Kantarjian HM, Hsu Y, Robeva AS, Rae P, Weitzman A, Meyer JM, Dugan M, Ottmann OG.

Leukemia. 2007 Nov;21(11):2311-5. Epub 2007 Jul 5.

PMID:
17611564
2.

Rapid expression cloning of receptors using epitope-tagged ligands and high-speed cell sorting.

Robeva AS, Yan-Neale Y, Burfeind P, Bodian DL, Chirn GW, Kolbinger F, Labow M, Vallon RD.

Cytometry A. 2003 Feb;51(2):59-67.

4.
5.
6.

A1 adenosine receptors. Two amino acids are responsible for species differences in ligand recognition.

Tucker AL, Robeva AS, Taylor HE, Holeton D, Bockner M, Lynch KR, Linden J.

J Biol Chem. 1994 Nov 11;269(45):27900-6.

7.

Molecular cloning and functional expression of a sheep A3 adenosine receptor with widespread tissue distribution.

Linden J, Taylor HE, Robeva AS, Tucker AL, Stehle JH, Rivkees SA, Fink JS, Reppert SM.

Mol Pharmacol. 1993 Sep;44(3):524-32.

PMID:
8396714
8.

Cloning and expression of a bovine adenosine A1 receptor cDNA.

Tucker AL, Linden J, Robeva AS, D'Angelo DD, Lynch KR.

FEBS Lett. 1992 Feb 3;297(1-2):107-11.

Supplemental Content

Loading ...
Support Center